These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28422391)

  • 1. MR elastography detection of early viscoelastic response of the murine hippocampus to amyloid β accumulation and neuronal cell loss due to Alzheimer's disease.
    Munder T; Pfeffer A; Schreyer S; Guo J; Braun J; Sack I; Steiner B; Klein C
    J Magn Reson Imaging; 2018 Jan; 47(1):105-114. PubMed ID: 28422391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease.
    Mirochnic S; Wolf S; Staufenbiel M; Kempermann G
    Hippocampus; 2009 Oct; 19(10):1008-18. PubMed ID: 19219917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer's disease in the APP23 mouse model.
    Pfeffer A; Munder T; Schreyer S; Klein C; Rasińska J; Winter Y; Steiner B
    Behav Brain Res; 2018 Jul; 347():300-313. PubMed ID: 29572105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining viscoelasticity, diffusivity and volume of the hippocampus for the diagnosis of Alzheimer's disease based on magnetic resonance imaging.
    Gerischer LM; Fehlner A; Köbe T; Prehn K; Antonenko D; Grittner U; Braun J; Sack I; Flöel A
    Neuroimage Clin; 2018; 18():485-493. PubMed ID: 29527504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance elastography to study the effect of amyloid plaque accumulation in a mouse model.
    Palotai M; Schregel K; Nazari N; Merchant JP; Taylor WM; Guttmann CRG; Sinkus R; Young-Pearse TL; Patz S
    J Neuroimaging; 2022 Jul; 32(4):617-628. PubMed ID: 35384128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-nucleus RNA sequencing reveals transcriptional changes of hippocampal neurons in APP23 mouse model of Alzheimer's disease.
    Zhong S; Wang M; Zhan Y; Zhang J; Yang X; Fu S; Bi D; Gao F; Shen Y; Chen Z
    Biosci Biotechnol Biochem; 2020 May; 84(5):919-926. PubMed ID: 31928331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice.
    Bondolfi L; Calhoun M; Ermini F; Kuhn HG; Wiederhold KH; Walker L; Staufenbiel M; Jucker M
    J Neurosci; 2002 Jan; 22(2):515-22. PubMed ID: 11784797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of sub-regional cerebral viscoelastic properties of 5XFAD Alzheimer's disease mice using multifrequency MR elastography.
    Majumdar S; Klatt D
    Magn Reson Med; 2021 Jul; 86(1):405-414. PubMed ID: 33604900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.
    Van Dam D; Vloeberghs E; Abramowski D; Staufenbiel M; De Deyn PP
    CNS Spectr; 2005 Mar; 10(3):207-22. PubMed ID: 15744222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice.
    Roder S; Danober L; Pozza MF; Lingenhoehl K; Wiederhold KH; Olpe HR
    Neuroscience; 2003; 120(3):705-20. PubMed ID: 12895511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice.
    Mahler J; Morales-Corraliza J; Stolz J; Skodras A; Radde R; Duma CC; Eisele YS; Mazzella MJ; Wong H; Klunk WE; Nilsson KPR; Staufenbiel M; Mathews PM; Jucker M; Wegenast-Braun BM
    Neurobiol Aging; 2015 Jul; 36(7):2241-2247. PubMed ID: 25911278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hippocampal and cognitive alterations precede amyloid deposition in a mouse model for Alzheimer's disease].
    Beauquis J; Vinuesa A; Pomilio C; Pavía P; Saravia F
    Medicina (B Aires); 2014; 74(4):282-6. PubMed ID: 25188653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice.
    Balakrishnan K; Rijal Upadhaya A; Steinmetz J; Reichwald J; Abramowski D; Fändrich M; Kumar S; Yamaguchi H; Walter J; Staufenbiel M; Thal DR
    Acta Neuropathol Commun; 2015 Jul; 3():41. PubMed ID: 26141728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease.
    Kuo YM; Beach TG; Sue LI; Scott S; Layne KJ; Kokjohn TA; Kalback WM; Luehrs DC; Vishnivetskaya TA; Abramowski D; Sturchler-Pierrat C; Staufenbiel M; Weller RO; Roher AE
    Mol Med; 2001 Sep; 7(9):609-18. PubMed ID: 11778650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.